Skip to content

ProMIO 2.0; a powerful lifestyle intervention for older adults from ethnic minorities

ProMIO 2.0; a powerful lifestyle intervention for older adults from ethnic minorities - ProMIO 2.0

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51916
Enrollment
126
Registered
2022-04-26
Start date
2022-05-24
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Loss of muscle mass and physical functioning

Interventions

The ProMIO intervention will be a 12 month personalized lifestyle intervention targeted at changing health behaviors in older adults from ethnic minorities in the Netherlands through dietary and phy

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Born in Turkey, Morocco, or Surinam (or at least one of the parents was born there) - Aged >=55 years - Physical ability and willingness to execute an MCE program - Ability and willingness to comply with the study protocol - Written informed consent - Consent of the study physician (ability to comply with the protocol in the opinion of the study physician, to ensure safety for the participant) - Willingness that the GP will be notified on study participation

Exclusion criteria

Exclusion criteria: - Aged 3 - Phase IV cancer - Diagnosed degenerative neurocognitive disorders - Active (para-)medical treatment interfering with this intervention - Current enrolment in a fixed rehabilitation program or other intervention studies - Palliative treatment or a life expectancy of 2 weeks planned in first three months of study or >2 months during the rest of the intervention period

Design outcomes

Primary

MeasureTime frame
Physical functioning measured by the 6 minute walk test (6MWT)

Secondary

MeasureTime frame
Physical functioning: • 30- seconds Chair Stand Test (30CST) • Single Leg Stance Test (SLST) Muscle strength and power: • Handgrip strength (handheld dynamometer (HGS)) • Lower extremity muscle strength (1-RM legpress and leg extension) • Lower extremity muscle strength (1-RM, Micro Force Evaluation and Testing (MicroFET)) Body composition/anthropometry: • Fat free mass, fat mass and total body water (Bodystat 1500 (BIA)) • Muscle quantity (2D ultrasound (2DUS)) • Body weight (calibrated weighing scale) • Height (cm from standing position) • Body Mass Index (BMI: kg/m2) Behavioral outcomes: • Dietary energy and protein intake (48-hr recall) • Physical activity (physical activity monitor (PAM)) Other outcomes: • Activities of Daily Lliving (Katz index (ADL)) • Frailty score (Rockwood) • Quality of Life (EQ-5D-5L and SarQoL questionnaires) • Feeling of depression and happiness (CES-D) • Pain, fear of falling, fatigue (Numeric rating scale, sFES-I) • Health care use and costs, out of pocket costs, productivity losses (MCQ +PCQ questionnaires) • Cost-effectiveness • Socio-demographic characteristics • Medical history • Adverse events • Adherence • Process evaluation

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)